Drug-induced Brugada Syndrome Research Database

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05048602

Enrollment

500

Registered

2021-09-17

Start date

2021-09-07

Completion date

2025-09-07

Last updated

2021-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Brugada Syndrome, ICD

Brief summary

All patients with drug-induced Brugada syndrome who are evaluated and followed at each participating centers will be recorded in this register. Within this register a characterization of patients and therapy will be done. Prognostic factors of adefined clinical relevant endpoints will be evaluated.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Inclusion criteria

* All consecutive patients with drug-induced Brugada Syndrome

Exclusion criteria

* Missing Informed Consent Form * Missing Contact Informations for Follow up

Design outcomes

Primary

Measure	Time frame	Description
Sudden Cardiac Death	1 year	Unexpected death due to cardiac causes that occurs in a short time period.
Appropriate ICD Therapies	1 year	Antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmia

Countries

Italy

Contacts

Primary ContactVincenzo Russo, MD PhD

vincenzo.russo@unicampania.it+390817062355

Outcome results